title: Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes.
authors: Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-Okayama, Japan. makino@md.okayama-u.ac.jp
authors: Hirofumi
authors: H
authors: Makino
authors: Masakazu
authors: M
authors: Haneda
authors: Tetsuya
authors: T
authors: Babazono
authors: Tatsumi
authors: T
authors: Moriya
authors: Sadayoshi
authors: S
authors: Ito
authors: Yasuhiko
authors: Y
authors: Iwamoto
authors: Ryuzo
authors: R
authors: Kawamori
authors: Masahiro
authors: M
authors: Takeuchi
authors: Shigehiro
authors: S
authors: Katayama
mesh_terms: D000328:Adult; D000368:Aged; D000419:Albuminuria; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use*; D003928:Diabetic Nephropathies / Q000503:physiopathology* / Q000517:prevention & control*; D004311:Double-Blind Method; D006801:Humans; D008875:Middle Aged; D010919:Placebos; D000077333:Telmisartan
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D001562:Benzimidazoles; D001565:Benzoates; D010919:Placebos; D000077333:Telmisartan